| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |